BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2020

Jan 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2020-01-14

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-01-14	Common Stock	M	8000	$21.51	Acquired	335530	Direct
2020-01-14	Common Stock	S	8000	$87.95	Disposed	327530	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-14	Stock Option (Right to buy Common Stock)	$21.51	M	8000	Disposed	2020-05-11	Common Stock (8000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	180261	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on November 13, 2019.

F2: The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's purchase of shares at a price of $75.3786 on November 11, 2019. The reporting person has paid to the Issuer the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs.

F3: Reflects the number of options outstanding after the transactions from this specific stock option grant.